Relationship of biogenic amines to behavior.
D000661:Amphetamine / Q000037:antagonists & inhibitors / Q000494:pharmacology; D000818:Animals; D001519:Behavior; D001921:Brain / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D004299:Dopamine beta-Hydroxylase / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology; D010134:Fenclonine / Q000494:pharmacology; D006801:Humans; D006892:Hydroxydopamines / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects; D008781:Methyltyrosines / Q000494:pharmacology; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009043:Motor Activity / Q000187:drug effects; D009474:Neurons / Q000187:drug effects; D009638:Norepinephrine / Q000502:physiology; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012653:Self Stimulation; D012701:Serotonin / Q000378:metabolism*; D013239:Stereotyped Behavior / Q000187:drug effects
D004791:Enzyme Inhibitors; D006892:Hydroxydopamines; D008781:Methyltyrosines; D008996:Monoamine Oxidase Inhibitors; D012701:Serotonin; D012110:Reserpine; D000661:Amphetamine; D004299:Dopamine beta-Hydroxylase; D010134:Fenclonine; D004298:Dopamine; D009638:Norepinephrine